VADIM KOROL: Open Payments
NPI 1417033812 · FRANKLIN SQUARE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 12 payments from 7 companies in 2025. Trend: 2023 $68 · 2024 $56 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $393 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| ACADIA Pharmaceuticals Inc | 1 | $31 |
| Agios Pharmaceuticals, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: REXULTI, Auvelity, FANAPT, INGREZZA, NUPLAZID, PYRUKYND, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
